Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications
EGFR inhibition down-regulates MGMT and enhances responsiveness to temozolomide in glioblastoma.
Journal: Science translational medicine
Published: July 08, 2026
DNA-PKcs inhibition sensitizes glioblastoma to radiotherapy through reprogramming of tumor cell states and immune microenvironment cell types.
Journal: Research square
Published: June 12, 2026
Cystic glioblastoma is associated with alterations of KDR and the Rb pathway: a single-center retrospective analysis.
Journal: Acta neuropathologica communications
Published: November 14, 2025
Genomic determinants of the diffusely infiltrative gliomatosis cerebri phenotype.
Journal: Journal of neuro-oncology
Published: June 27, 2025
Molecular and clinical determinants of response to checkpoint inhibitor immunotherapy in glioblastoma.
Journal: Journal of neuro-oncology
Published: May 12, 2025
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses : Treatment intensification, margin reduction and epigenetic stratified outcomes with radiation therapy and chemotherapy.
Journal: Journal of neuro-oncology
Published: May 05, 2025
Immune Checkpoint Inhibitor Therapy for Aggressive Pituitary Neuroendocrine Tumors.
Journal: The Journal of clinical endocrinology and metabolism
Published: December 06, 2024
The Impact of MRI-Based Advanced Neuroimaging on Neurooncologists' Clinical Decision-Making in Patients With Posttreatment High-Grade Glioma: A Prospective Survey-Based Study.
Journal: AJR. American journal of roentgenology
Published: August 14, 2024
Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid Tumors.
Early Outcomes from Proton Craniospinal Irradiation for Leptomeningeal Metastasis From Solid Tumors.
Journal: Advances in radiation oncology
Published: August 01, 2024
Last Updated: 09/26/2026